Sign in to continue:

Tuesday, January 27th, 2026

Alibaba Health Information Technology Ltd: Bottom Reversal Signals Strong Upside Potential

Date of Report: September 26, 2024
Broker Name: CGS International


Company Overview

Alibaba Health Information Technology Ltd (HKG: 241) is an integrated healthcare information and content service provider. The company utilizes a product identification, authentication, and tracking system to deliver healthcare information services.


Recent Stock Performance

Alibaba Health has recently exhibited a bottom reversal in its stock performance. The current stock price stands at HK$3.55, with a recent rebound from the buy limit price of HK$2.75. The stock shows strong potential for an upward trend, based on the technical analysis indicators.


Entry and Exit Strategy

  • Entry Prices: HK$3.55, HK$3.13, HK$2.85
  • Support Levels:
    • Support 1: HK$3.07
    • Support 2: HK$2.75
  • Resistance Levels:
    • Resistance 1: HK$3.86
    • Resistance 2: HK$4.97
  • Stop Loss: HK$2.58
  • Target Prices:
    • Target 1: HK$4.15
    • Target 2: HK$4.90
    • Target 3: HK$5.50
    • Target 4: HK$6.00

Technical Indicators

The analysis highlights several positive indicators that support the upward trend:

  1. Double Bottom Reversal Pattern: The stock has formed a double bottom reversal pattern. A break above the falling wedge, with strong volume and price action, signals a higher probability of completing this pattern.
  2. Ichimoku Indicators: Prices are trending above all Ichimoku indicators, further reinforcing the bullish sentiment.
  3. MACD Indicator: The MACD histogram is positive, and both the MACD and signal lines are continuing to rise after a recent crossover.
  4. Stochastic Oscillator: The oversold crossover in the stochastic oscillator has been confirmed.
  5. Rate of Change (ROC): The 23-period ROC is rising strongly and remains above the zero line, signifying momentum.
  6. Directional Movement Index (DMI): The DMI indicates strong bullish pressure.
  7. Volume: Volume remains healthy, surpassing the 20-period average, reflecting strong interest in the stock.

This comprehensive analysis suggests that Alibaba Health Information Technology Ltd is poised for a potential price increase, driven by favorable technical indicators and strong market sentiment.

CapitaLand Investment Ltd: Driving Growth in Singapore Real Estate with Strategic Expansion – Maybank Research Report [[Page 1]]

CapitaLand Investment Ltd (CLI SP): Positioning for Growth Broker: Maybank Research Pte Ltd Date of Report: February 28, 2025 Overview CapitaLand Investment Ltd (CLI SP) has reported significant growth in its financial performance for...

CGS Maintains Add on ESR-REIT: Solid 1Q25, Attractive 10.3% Yield, S$0.36 TP

CGS International Securities Singapore Pte. Ltd. April 23, 2025 ESR-REIT Poised for Growth: Q1 Strength, 10%+ Yield, and Strategic Moves Underpin ‘Add’ Rating ESR-REIT (EREIT) demonstrated a promising start to the year, with its...

DXN Holdings (DXN MK): Maintain BUY on In-Line FY25 Results | MYR0.72 TP & >8% Yield | Maybank Analysis

Maybank Investment Bank Berhad April 30, 2025 DXN Holdings (DXN MK): Steady FY25 Performance Fuels BUY Rating Amid Latin American Expansion & Attractive Yields DXN Holdings (DXN MK) reported fourth-quarter fiscal year 2025 (4QFY25)...